FIND PERSONALIZED JOBS
Sign up to Zippia and discover your career options with your personalized career search.
×
FIND
PERSONALIZED JOBS

Log In

Log In to Save

Sign Up to Save

Sign Up to Dismiss

Sign Up

or

The email and password you specified are invalid. Please, try again.

User already exist with emailId.

Email and password are mandatory

Forgot Password?

Don't have an account? Sign Up

reset password

Enter your email address and we will send you a link to reset your password.

Back to Log In

Log In

Log In to Save

Sign Up to Save

Sign Up to Dismiss

Sign up to save the job and get personalized job recommendations.

Sign up to dismiss the job and get personalized job recommendations.

or

The email and password you specified are invalid. Please, try again.

Email and password are mandatory

Already have an account? Log in

reset password

Enter your email address and we will send you a link to reset your password.

Back to Log In

Company Saved

Answer a few questions and view jobs at Ignyta Inc that match your preferences.

Where do you want to work?

Job Saved

See your Saved Jobs now

or

find more interesting jobs in

Job Dismissed

Find better matching jobs in

Generic Logo
SIGN UP
  • Sign up with Facebook
  • Sign up with Google
We will never post anything without your permission.
Creating an account means you're okay with our terms of service and privacy policy.

Already have an account? Login

Working At Ignyta Inc

Zippia Score 4.1

Review Submitted!

Ignyta Inc

Ignyta Inc Overview

Industry

Biotechnology

Organization Type

-

Employees

100 - 500

Headquarters

San Diego, CA

Website

www.ignyta.com

Website

www.ignyta.com



Founded in

2011

Revenue

-

Key People

Jacob Chacko (Executive Officer),
Ph Heiner Dreismann (Director),
J Matt Onaitis (Executive Officer),
Zachary Hornby (Executive Officer),
Ph James Bristol (Director),
James Freddo (Director),
Pratik Multani (Executive Officer),
Ph Valerie Harding (Executive Officer),
Ph Igor Bilinsky (Executive Officer),
Alex Casdin (Director),
Bernard Parker (Executive Officer),
Ph Robert Wild (Executive Officer),
Jonathan Lim (Executive Officer, Director)

Show More

About Ignyta Inc

Ignyta, Inc., a precision oncology biotechnology company, engages in discovering, in-licensing or acquiring, developing, and commercializing molecularly targeted therapies for eradicating residual diseases. Its products pipeline includes entrectinib, a tyrosine kinase inhibitor directed to the tropomyosin receptor kinase family tyrosine kinase receptors, ROS1, and anaplastic lymphoma kinase proteins, which is in Phase II and two Phase I clinical studies in molecularly defined adult patient populations for the treatment of solid tumors, as well as in Phase I/Ib clinical study in pediatric patients with advanced solid tumor malignancies; RXDX-105, an orally bioavailable and vascular endothelial growth factor receptor, and small molecule tyrosine kinase inhibitor of RET-driven solid tumors; and RXDX-106, a pseudo-irreversible inhibitor, which is in late preclinical development. The company was founded in 2011 and is headquartered in San Diego, California.

Show More

Ignyta, Inc., a precision oncology biotechnology company, engages in discovering, in-licensing or acquiring, developing, and commercializing molecularly targeted therapies for eradicating residual diseases. Its products pipeline includes entrectinib, a tyrosine kinase inhibitor directed to the tropomyosin receptor kinase family tyrosine kinase receptors, ROS1, and anaplastic lymphoma kinase proteins, which is in Phase II and two Phase I clinical studies in molecularly defined adult patient populations for the treatment of solid tumors, as well as in Phase I/Ib clinical study in pediatric patients with advanced solid tumor malignancies; RXDX-105, an orally bioavailable and vascular endothelial growth factor receptor, and small molecule tyrosine kinase inhibitor of RET-driven solid tumors; and RXDX-106, a pseudo-irreversible inhibitor, which is in late preclinical development. The company was founded in 2011 and is headquartered in San Diego, California.

Show More

What Is

Ignyta Inc's Mission Statement

?
We burn to be the best precision medicine company in the world by quenching the affliction of cancer. We use trailblazing scientific methods and adaptive business models to fuel exceptional patient benefit, employee engagement, and shareholder value.

Is This Your Company?

Do You Work At Ignyta Inc?

What is it like to work at Ignyta Inc

Ignyta Inc Salaries

  • -
    Salary Score
We calculated the salary score by comparing the salaries of specific positions within a given company against other similar positions at other similar companies.
Organic ChemistSan Diego, CA $55,000
Research AssociateSan Diego, CA $55,000

No Results

To get more results, try adjusting your search by changing your filters.

Show More

Ignyta Inc Stock Performance

  • -
    Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Ignyta Inc Financing Rounds

Date Amount Security Type
Nov 16, 2015Equity $39,000,000
Dec 9, 2013Equity $7,620,576
Nov 12, 2013Equity $46,440,852
Jan 3, 2013Equity $7,000,000
Show More

How Would You Rate The Company Culture Of Ignyta Inc?

Have you worked at Ignyta Inc? Help other job seekers by rating Ignyta Inc.

You can find out what it is like to work at Ignyta Inc, also known as IGNYTA INC, Ignyta Inc and Ignyta, Inc..

Zippia gives an in-depth look into the details of Ignyta Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ignyta Inc. The employee data is based on information from people who have self-reported their past or current employments at Ignyta Inc. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Ignyta Inc and its employees or that of Zippia.